Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.56 |
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | XBP1 | P17861 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.54 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL366266 | 0.91 | MGLL (0.65) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL19514746 | 0.89 | MGLL (0.70) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL18040141 | 0.87 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL19514774 | 0.87 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL179955 | 0.87 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL3482393 | 0.78 | MGLL (0.54) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14587456 | 0.78 | MGLL (0.54) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14678413 | 0.78 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL145737 | 0.78 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL2639486 | 0.76 | MGLL (0.50) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2125 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239885-A1 | ANTIBODY CONJUGATE COMPRISING ANTI-P-CADHERIN ANTIBODY AND USES THEREOF | WuXi Biologics Ireland Limited (IE) | 2024-07-18 | — | — | US | claimed |
| WO-2023195805-A9 | ITGB2-MEDIATED DRUG DELIVERY SYSTEM | 트윈피그바이오랩(주) | 2024-07-11 | — | — | WO | claimed |
| US-20240156978-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | ANGIEX, INC. | 2024-05-16 | — | — | US | claimed |
| WO-2024044550-A1 | DLL3 BINDING MOLECULES AND USES THEREOF | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | claimed |
| EP-4321526-A1 | PEPTIDE LIGAND TARGETING CARBONIC ANHYDRASE IX, PEPTIDE CONSTRUCT COMPRISING SAME, AND USES THEREOF | C-Biomex Co., Ltd. (KR) | 2024-02-14 | — | — | EP | claimed |
| US-20240043512-A1 | EPITOPES OF ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK) ANTIBODIES | IMCARE BIOTECH LLC | 2024-02-08 | — | — | US | claimed |
| EP-4313009-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| US-11866496-B2 | Humanized anti-CD79B antibodies and immunoconjugates and methods of use | GENENTECH, INC. (US) | 2024-01-09 | — | — | US | claimed |
| EP-4294845-A1 | IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY | Abdera Therapeutics Inc. (US) | 2023-12-27 | — | — | EP | claimed |
| US-11833222-B2 | CL and/or CH1 mutated antibodies for drug conjugation | LONZA LTD (CH) | 2023-12-05 | — | — | US | claimed |
| WO-2009099728-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2009-08-13 | — | — | WO | claimed |
| EP-2061814-A2 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR | Genentech, Inc. (US) | 2009-05-27 | — | — | EP | claimed |
| US-20090068202-A1 | Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use | GENENTECH, INC. (US) | 2009-03-12 | — | — | US | claimed |
| EP-2032606-A2 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR | Genentech, Inc. (US) | 2009-03-11 | — | — | EP | claimed |
| US-20090028856-A1 | Anti-CD79B Antibodies and Immunoconjugates and Methods of Use | GENENTECH, INC. (US) | 2009-01-29 | — | — | US | claimed |
| WO-2009012268-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2009-01-22 | — | — | WO | claimed |
| WO-2009012256-A1 | HUMANIZED ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2009-01-22 | — | — | WO | claimed |
| WO-2008052187-A2 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR | GENENTECH. INC. (US) | 2008-05-02 | — | — | WO | claimed |
| US-20080050310-A1 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR | GENENTECH, INC. (US) | 2008-02-28 | — | — | US | claimed |
| WO-2007140371-A2 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR | GENENTECH, INC. (US) | 2007-12-06 | — | — | WO | claimed |